Skip to content
Review

Abstract 13394: Early versus Delayed Surgery or Conventional Therapy for Infective Endocarditis: A Contemporary Systematic Review and Meta-Analysis

Nov 2026 · Circulation · 0 citations

Abstract

Background: The optimal timing of surgery for infective endocarditis (IE) remains controversial, with variable evidence regarding the benefits of early surgery. We performed a systematic review and meta-analysis to evaluate the impact of early surgery on mortality and clinical outcomes in patients with IE. Methods: A systematic search of MEDLINE, Embase, CENTRAL, Scopus, CINAHL, and Web of Science was conducted from inception through April 2026. Randomized controlled trials and comparative observational studies evaluating early surgery versus delayed surgery or conventional medical therapy in adults with IE were included. Early surgery was defined as surgery performed during the index hospitalization or earlier. Sensitivity analyses evaluated various surgical timing definitions, including American Heart Association (AHA)/American College of Cardiology (ACC) definition of early surgery and European Society of Cardiology (ESC) definition of non-urgent surgery during the index hospitalization, as well as surgery within ≤7 days and 8-14 days from diagnosis. ESC timing definitions of emergent/urgent surgery (within 24-72 hours) were also assessed. The primary outcome was all-cause mortality. Secondary outcomes included in-hospital mortality and major complications. Random-effects models were used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Results: A total of 53 studies with 16,121 patients were included. Overall, early surgery during index hospitalization or earlier was associated with significantly lower all-cause mortality compared with delayed surgery or conventional therapy (OR, 0.66; 95% CI, 0.53-0.83), although heterogeneity was substantial (I 2 =80%). In studies using the AHA/ESC definition of non-urgent surgery, early surgery was associated with significantly lower all-cause mortality (OR, 0.48; 95% CI, 0.39-0.60). In contrast, surgery performed within ≤7 days (OR, 1.08; 95% CI, 0.68-1.70) or within 8-14 days (OR, 0.76; 95% CI, 0.21-2.74) was not associated with significant mortality reduction compared to delayed surgery or conventional therapy. Using ESC timing definitions of emergent/urgent surgery within 24-72 hours, early surgery (OR, 0.36; 95% CI, 0.08-1.64) did not demonstrate significant mortality benefit. Early surgery was also associated with lower in-hospital or 30-day mortality (OR, 0.73; 95% CI, 0.56-0.96). No significant differences were observed in cerebrovascular complications, embolic events, recurrence of IE, or hospital length of stay. Conclusions: Early surgery according to AHA/ACC definition in infective endocarditis is associated with lower all-cause and in-hospital mortality. However, the mortality benefit appears less pronounced across other early surgical timing definitions.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.